Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.36 |
| ▸ | KARS1 | Q15046 | 2/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9572335 | 0.82 | HSD11B1 (0.47) | HSD11B1ALDH1A1 | |
| SCHEMBL11759010 | 0.82 | HSD11B1 (0.47) | HSD11B1ALDH1A1 | |
| SCHEMBL32688629 | 0.79 | HSD11B1 (0.37) | HSD11B1 | |
| SCHEMBL5930739 | 0.78 | HSD11B1 (0.37) | HSD11B1 | |
| SCHEMBL32689275 | 0.77 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL32688805 | 0.76 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL27564593 | 0.74 | HSD11B1 (0.32) | HSD11B1ALOX5APALDH1A1 | |
| SCHEMBL32688595 | 0.74 | HSD11B1 (0.35) | HSD11B1ALDH1A1 | |
| SCHEMBL32689077 | 0.74 | HSD11B1 (0.35) | HSD11B1EPHX2 | |
| SCHEMBL7861571 | 0.74 | HSD11B1 (0.33) | HSD11B1ALOX5APEPHX2CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9896537-B2 | Norbornanyl rosin resin and process for preparing same | YU HUI (US) | 2018-02-20 | — | — | US | disclosed |
| US-9353213-B2 | Functional norbornanyl ester derivatives, polymers and process for preparing same | YU HUI (US) | 2016-05-31 | — | — | US | disclosed |
| US-20160122469-A1 | Functional norbornanyl ester derivatives, polymers and process for preparing same | YU HUI (US) | 2016-05-05 | — | — | US | disclosed |
| US-8883897-B2 | Functional norbornanyl ester derivatives, polymers and process for preparing same | New Functional Polymers LLC (US) | 2014-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122469-A1 | Functional norbornanyl ester derivatives, polymers and process for preparing same | CYP1B1, DECR1, CAD | HSD11B1 149/4885KARS1 888/4885ALOX5AP 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.